GlassScriptPhysician profile
John G Durham
NPI 1235103268
$1,994.23
in general payments reported to CMS, 2019-2025
27 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $156 · 2021: $411 · 2022: $189 · 2023: $336 · 2024: $208 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $755.34 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $227.04 | 2020-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Melinta Therapeutics, LLC | $124.99 | 2019 | |
| Paratek Pharmaceuticals, INC. | $108.59 | 2021-2025 | Nuzyra |
| Nevro Corp. | $96.21 | 2023-2024 | Senza |
| Amgen INC. | $84.28 | 2024-2025 | Krystexxa |
| Bard Peripheral Vascular, INC. | $77.26 | 2021 | |
| Abbott Laboratories | $67.35 | 2020-2024 | Axium, Proclaim |
| Ermi LLC | $55.67 | 2019-2020 | |
| Next Science LLC | $32.08 | 2024 | Xperience, Surgx, Blastx |
| Integra Lifesciences Corporation | $31.84 | 2019 | |
| Zimmer Biomet Holdings, INC. | $29.93 | 2024 | Max Vpccannulated Drill |
| Cashflow Solutions, LLC | $29.07 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Kowa Pharmaceuticals America, INC. | $28.02 | 2022 | |
| Kerecis Limited | $25.51 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.40 | 2025 | Jublia |
| Pacira Pharmaceuticals Incorporated | $23.37 | 2025 | Exparel |
| Medtronic, INC. | $23.36 | 2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $21.94 | 2025 | Accolade Sr |
| Aroa Biosurgery Incorporated | $21.88 | 2025 | |
| Tenex Health INC. | $18.48 | 2021 | |
| Depuy Synthes Sales INC. | $17.94 | 2024 | |
| Averitas Pharma INC. | $15.17 | 2023 | Qutenza |
| Bioventus LLC | $14.14 | 2023 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $14.13 | 2025 | Senza |
| Horizon Therapeutics Plc | $14.04 | 2021 | |
| Rgh Enterprises LLC | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.